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Abstract. H36 is a 120,000-D membrane glycoprotein
that is expressed during the differentiation of skeletal
muscle. H36 cDNA clones were isolated from a lambda
UniZapXR rat myotube cDNA library and sequenced.
The deduced amino acid sequence demonstrates that
H36 is a novel integrin alpha chain that shares exten-
sive homology with other alpha integrins that in-
cludes: (a) the GFFKR sequence found in all alpha
integrins; (b) a single membrane spanning region; (c)
conservation of 18 of 22 cysteines; and (d) a protease
cleavage site found in the non-I region integrin alpha
chains. The cytoplasmic domain of H36 is unique and
additional regions of nonhomology further indicate
H36 is distinct from all other alpha chains. In keeping
with current nomenclature we designate this alpha
chain 0. Northern blots demonstrate that expression
of H36-a7 mRNA is regulated both early in the devel-
opment of the myogenic lineage and later, during ter-
minal differentiation . Detection of H36-a7 mRNA
coincides with conversion of H36- myogenic precursor
A
A continuum of cell interactions takes place throughout
the differentiation of skeletal muscle : distinct cell
and molecular interactions underlie the development
and function ofeach stage. In the early stages ofmyogenesis
cellsreplicate, migrate, and maintain an autonomy from one
another that is typical of most other cells. During this stage
the primary interactions of cellsare with their molecular en-
vironment that includes nutrients, growth factors, and extra-
cellular matrix proteins. This serves to increase cell mass
and localize the sites of future development. Subsequently,
upon termination of the proliferative stage, the cells interact
and fuse to form elongate fibers. At this same stage of devel-
opment the genes that encode the myofibrillar proteins and
ATP-generating enzymes are expressed. The transition be-
tween these stages of myogenic development is regulated by
the interactions of heterodimeric complexes of helix-loop-
helix proteins with regulatory sites in the genome (Murre et
al., 1989; Davis et al ., 1990 ; for review see Olson, 1990)
and by the interactions of cells with growth factors (Lim and
Hauschka, 1984; Ewton and Florini, 1990; Massague et al.,
1986; Jin et al., 1991) and extracellular matrix proteins (Fos-
ter et al., 1987; Ocalan et al., 1988) . The assembly of the
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cells to H36+ cells. H36-a7 mRNA is present in repli-
cating myoblasts: expression increases upon terminal
differentiation and is markedly reduced in develop-
mentally defective myoblasts. In addition, H36-a7
mRNA is not detected in C3H10T1/2 cells. It is in myo-
tubes derived from myoblasts obtained by treatment of
IOTl/2 cells with azacytidine or transfection with
MRF4 . Immunoblots and immunofluorescence demon-
strate that the H36-a7 chain is associated with integ-
rin 01. Affinity chromatography demonstrates that
1136-a7ß1 selectively binds to laminin. The expres-
sion of H36-a7 on secondary myoblasts during the de-
velopment of the limb in vivo corresponds with the
appearance of laminin in the limb, with the responsive-
ness of secondary myoblast proliferation to laminin,
and with the onset of increased muscle mass, suggest-
ing that H36-a7 modulates this stage in limb develop-
ment . We conclude that H36-a7 is a novel alpha in-
tegrin laminin binding protein whose expression is
developmentally regulated during skeletal myogenesis.
contractile proteins into sarcomeres and interactions be-
tween fibers and nerve cells results in the formation of func-
tional muscle, responsive to neuronal input . Extracellular
matrix proteins may promote sarcomere assembly (Volk et
al ., 1990) as well as localize acetylcholine receptors (Axel-
rod et al ., 1976; Dymtrenko et al., 1990). Neuromuscular
junctions are formed and stabilized by further molecular in-
teractions, each cell type providing specific proteins (Fallon
et al., 1985 ; Bloch and Froehner, 1987; Hunter et al., 1989;
Carr et al., 1989) . Specific ion channels and transport pro-
teins in the muscle membrane produce the ionic discontinui-
ties between muscle and the extracellular environment that
are essential to muscle activation. Formation of myotendi-
nous junctions and additional anchoring of the skeletal fibers
further stabilize the muscle and direct movement. Dystro-
phin, the protein defective or absent in patients with Du-
chenne muscular dystrophy (Bonilla et al., 1988), and integ-
rin, the extracellular matrix receptor (Bozyczko et al ., 1989),
may be of particular importance to this latter stage of devel-
opment. Thus as cells develop from precursors to myoblasts
to functional contractile fibers diverse interactions occur on
the plasma membrane. A remodeling of the membrane that
643presumably reflects these diverse events accompanies each
stage of development (Kaufman and Foster, 1985) . The spe-
cific molecules in the membrane and mechanisms that un-
derlie each of these stages of myogenic development are
known to differing degrees.
One membrane protein, H36, has proven useful as a cell
surface marker to identify and isolate myogenic cells. H36
is a developmentally regulated integral membrane glycopro-
tein on skeletal muscle (Kaufman et al ., 1985). It was origi-
nally identified using immunofluorescence and isolated by
immunoaffinity chromatography with a mAb. H36 is ex-
pressed on replicating myoblasts and this expression is in-
creased before fusion. This upregulation is dependent on
new transcription and is inhibited by a variety of conditions
which inhibit differentiation (Kaufman et al ., 1985 ; Kauf-
man, 1990) . Cells selected from heterogeneous populations
by flow cytometry basedon theirexpression of H36 differen-
tiate into skeletal muscle (Schweitzer et al., 1987; Kaufman
and Foster, 1988). Mutants isolated from the L8E63 myo-
genic line based on their lack of expression of H36 do not
differentiate. H36 has also served as a marker for identifying
cells in the myogenic lineage (Kaufman and Foster, 1988).
Precursor cells in the embryonic limb bud do not initially ex-
press H36, but do so upon subsequent development (Kauf-
man et al., 1991). Immunocytochemistry of cryosections
confirms the expression of H36 on fetal skeletal muscle in
vivo and has contributed to demonstrating that H36 is ex-
pressed at different stages during the formation of primary
and secondary fibers (Kaufman et al., 1991; George-Wein-
stein, M ., manuscript submitted for publication) . During
primary myogenesis, H36 is first expressed upon terminal
differentiation whereas during secondary myogenesis it is
present on replicating myoblasts and its expression is subse-
quently upregulated upon terminal differentiation.
Because of the developmental specificity and regulation of
H36 during the embryonic and fetal development of skeletal
muscle we have cloned the H36 gene to determine the struc-
ture and function ofthis protein. In these experiments we re-
port the cloning and sequencing of H36 cDNA and its
identification as a novel integrin alpha chain .
Materials and Methods
Cells
L8E63 cells, a myogenic clone of L8 rat skeletal myoblasts and fu-1 cells,
a developmentally defective clone of L8, that have lost normal growth con-
trol, were grown in DME supplemented with 10% horse serum (Gibco Lab-
oratories, Grand Island, NY) as described (Kaufman and Parks, 1977).
C2A3 myoblasts, subcloned from the C2 line of mouse satellite cells (Yaffe
et al ., 1977), and 23A2A myoblasts, subcloned from the 23A2 myogenic
cells derived by treatment of C3H10I'1/2 cells with 5-azacytidine (Konieczny
et al., 1984), were grown in 15% colostrum-free bovine serum (Irvine Sci-
entific, Santa Ana, CA) in DME. MRF4#7 mouse myogenic cells, derived
by transfection of C3H10T1/2 cells with MRF4 cDNA (Rhodes and Koni-
eczny, 1989), and BC3H1 non-fusing mouse myoblasts (Schubert et al.,
1974) were grown in 20% FBS (Sigma Chemical Co., St. Louis, MO) in
DME; RMo rat myoblasts (Merrill, 1989) were grown in 15% FBS. The
23A2 and MRF4 myogenic lines wereprovided by Drs. C. Emerson, Jr. (Fox
Chase Institute, Philadelphia, PA) and S. Konieczny (Purdue University,
Lafayette, IN), respectively. C2 cells and BC3H1 cells wereprovided by Dr.
E. Olson (M. D. Anderson Cancer Center, Houston, TX) and RMo myo-
blasts were provided by Dr. G. Merrill (Oregon State University, Corvallis,
OR). PCl human satellite cells were obtained from Dr. H. Blau (Stanford
University, Stanford, CA) and grown in F10 medium containing 20% FBS,
and 0.5% chick embryo extracted as described (Blau and Webster, 1981).
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Differentiation was promoted in these cell lines by growth in 2% horse ser-
um. The quail myogenic line, QM7, provided by Drs. P. Antin and C. Or-
dahl (University ofCalifornia, San Francisco, CA), was grown in medium
199 containing 10% FBS and 10% tryptone phosphate and allowed to dif-
ferentiate in 0.5% FBS in medium 199 (Antin and Ordahl, 1991). C3H-
10f1/2 cells (Reznikoff et al., 1973) were provided by Dr. P. Jones (Uni-
versity of Southern California, Los Angeles, CA) and grown in 10% horse
serum. BHK cells were grown in DME containing 10% FBS and 10% tryp-
tone phosphate. Primary cultures of Sprague/Dawley newborn rat thigh
muscle (Holtzman) were prepared as described by Foster et al. (1987). Em-
bryonic day 12 cultures of hindlimb buds were prepared from rats in timed
pregnancy and serially passaged as described (Kaufman et al., 1991). Chick
embryo muscle cultures were prepared from day 12 White Leghorn em-
bryos (O'Neill and Stockdale, 1972). All media were supplemented with
100 U/ml penicillin, 100 kg/ml streptomycin, and 10 kg/ml kanamycin and
all cultures were grown at 37°C, in 10% C02.
Antibodies
H36 protein was isolated by immunoaffinity chromatography. The hind-
limbs of 120 5-d-old rat pups were skinned, feet removed, teased in 40 ml
buffer A (250 mM KCI, 1 mM CaC12, 3 MM MgC12, 200 mM sucrose, 1%
aprotinin, 100 kM PMSF, 50 /M Tris-maleate, pH 5.5), and homogenized
in an equal volume ofbuffer A in a Polytron (3 x 10 s at setting 6). CHAPS
was added to a final concentration of 10 mM and the homogenate was ex-
tracted overnight, with stirring at 4°C. The supernatant from sequential
centrifugations at 1,500 g for 15 min, 10,000 g for 15 min, and 110,000 g
for 1 h was filtered through Whatman No. 1 filter paper (Whatman Inc.,
Clifton, NJ), passed through a 2-ml glass wool columnand a2-ml Affigel-10
column (Bio-Rad Laboratories, Cambridge, MA) coupled with 10 mg/ml
purified anti-H36 antibody (Kaufman etal ., 1985). The column was washed
with 500 mM NaCI, 1 mM EDTA, 10 mM CHAPS, 0.02% NaN3, 50 MM
Hepes, pH 8.0 and then with 150 mM NaCl, 10 mM CHAPS, 0.02%
NaN3, 50 mM Hepes, pH 8.0, until A280 = 0. Bound H36 was eluted in
0.5 M acetic acid, pH 2.0.
BALB/c mice, 8-wk old, were immunized four times, at 3-wk intervals,
with 100 Al containing 35 gg antigen in RIBI adjuvant (Ribi Immunochem
Research, Inc., Hamilton, MT). Hybridomas were prepared by fusion of
immune spleen cells with SP2/0 cells in the University of Illinois Cell Sci-
ence Center (Urbana, IL) . Supernatants were screened by immunofluores-
cence and immunoblotting. All positive clones were subcloned and retested
for reactivity and specificity. The 05 antibody reacts with purified H36 in
immunoblots and was used to screen the cDNA library. The 014-1 antibody
reacts with integrin ßl chain in the affinity purified H36 complex and myo-
tubes lysates. 026 antibody reacts with purified H36 in immunoblots and
on cells. Rabbit antisera specific for the cytoplasmic domains of integrin
ßl (two sera provided by Drs. C. Buck, Wistar Institute, Philadelphia, PA
and A. F. Horwitz, University of Illinois, Urbana, IL), 03 (Dr. M. Gins-
berg, Scripps Institute, La Jolla, CA), /34 and 06 (Dr. V. Quaranta, Scripps
Institute, LaJolla, CA) and 05 (Dr. L. Reichardt, University of California,
San Francisco, CA), and for extracellular determinants on ßl (two sera pro-
vided by Drs. C. Buck and K. Yamada, NIH, Bethesda, MD) were gener-
ously provided as indicated.
InUilunofuorescence
Cells cultured on No. 1 glass coverslips (Bellco Glass, Inc., Vineland, NJ)
coated with 0.1% gelatin, and cryosections prepared from adult Sprague-
Dawley thigh muscle were processed for immunofluorescence as reported
(Kaufmanet al., 1991) . H36 anti-alpha chainantibody, purified from ascites
fluid, was used at a dilution of 5 l,g/ml. 014-1 anti-ßl antibody in hybrid-
oma culture fluid was used undiluted, and rabbit antibody reactive with the
cytoplasmic domain of integrin 01 chain (provided by Dr. A . F. Horwitz),
partially purified by ammonium sulfate precipitation, was used at a 1:100
dilution. Rabbit IgG purified by ammonium sulfate precipitation and SP2/0
culture fluid were used as negative controls. Fluorescein- or rhodamine-
conjugated donkey anti-mouseanddonkey anti-rabbit IgG (Jackson Immu-
noResearch Laboratories Inc., Avondale, PA) were used as secondary anti-
bodies. In the double label experiments with H36 and 014-1 antibodies, live
cells were first reacted with 014-1 antibody, then with fluorescein-anti-
mouse IgG, followed by purified normal mouse IgG. Biotinylated anti-H36
antibody was then added, followed by rhodamine-avidin and the cells were
fixed. In the double label experiments with anti-H36 and anti-al cytoplas-
mic domain antiserum, live cells were first reacted with anti-H36 antibody,
and then with rhodamine-anti-mouse IgG. The cells were then fixed (and
permeabilized) with 95 % ethanol and reacted with rabbit anti-/31 antiserum
644followed by fluorescein-anti-rabbit IgG. The coverslips were mounted in
glycerol/PBS 9/1 (vol/vol), pH 8.5, containing 10 mMp-phenylenediamine
(Eastman, Rochester, NY), sealed with Flo-texx (Fisher Scientific Co., Pitts-
burgh, PA), and examined with a photomicroscope III (Carl Zeiss, Inc.,
Oberkochen, Germany) equipped with epi-illumination optics and an HBO
100-W mercury lamp.
ImmunoblotAnalysis
The samples ofpurified H36 protein or myotubes lysates were separated in
0.75-mm thick, 8% polyacrylamide minigels (Laenimli, 1970) . Cell lysates
were prepared by sonication (three times, for 10 s, at 4°C) in PBS contain-
ing 1 mM PMSF. Electrophoresis was at 100 V for 10 min, then 120 V for
50 min at room temperature. The gels were equilibrated in 25 mM Tris,
200 mM glycine, pH 8.8, and 20% methanol for 10 min at 4°C, and the
proteins transferred to nitrocellulose at 100V for 60 min. The filters were
blockedwith 2 % gelatin in TBST (100mM Tris-HCI pH 8.0, 150 mM NaCl
and 0.05% Tween-20), reacted with primary antibodies, followed by alka-
linephosphatase conjugated goat anti-mouse immunoglobulin (Jackson Im-
munoresearch). Immunoreactive proteins were visualized with nitroblue
tetrazolium (NBT)' and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in
150 mM NaCl, 5 mM EDTA, and 100 mM Tris-HCl, pH 9.5.
RNA Analysis
Poly(A)+ RNAs were purified according to Badley et al. (1988) . Cultured
cells were collected, pelleted, and lysed in 200 mM NaC1, 1.5 MM MgC12,
2 .0% SDS, 0.2 M Tris-HCI, pH 7.5, and 200 Ag/ml proteinase K. The
poly(A)+ RNAs were purified using oligo dT cellulose (Collaborative Re-
search Inc., Waltham, MA), electrophoresed in 1% agarose gels containing
2 .2 M formaldehyde, and transferred onto GeneScreen plus (DuPont-NEN
Products, Wilmington, DE) by capillary action (Sambrook et al ., 1989).
The filters were prehybridized at 65°C for 2-3 h in 1% gelatin, 7% SDS,
100 Ag/ml salmon sperm DNA, 1 mM EDTA, 0.55 M sodium phosphate
buffer, pH 7.2, and then hybridized with probes labeled by random primer
labeling (Oligolabeling Kit; Pharmacia Fine Chemicals, Piscataway, NJ)
using [a-p321 dCTP (3,000 Ci/mmol; Amersham Corp., Arlington Heights,
IL). The filters were washed three times with 0.2x SSC (150 mM NaCl,
15 mM sodium citrate, pH 7.0) and 0.1% SDS at 65°C and exposed to x-ray
film (Dupont Co.) for 12-72 h.
Myosin heavy chain (MHC) pMHC25 plasmid, provided by Dr. B.
Nadal-Ginard (Harvard University, Boston, MA), was used to prepare a
360-bp Pstl fragment (Medford et al., 1980) . The pEMCI is myogenin plas-
mid (Wright et al., 1989), provided by Dr. W. Wright (University of Texas
SW Medical Center, Dallas, TX), was used to prepare a 1 .5-kb EcoRI frag-
ment. Labeled H36 probe was prepared from a 2 .3-kb EcoRI and Xhol re-
striction fragment of the 05B clone selected from the library. The restric-
tion fragments were isolated by electrophoresis in 0.8% low melting agarose
(International Biotechnologies, Inc., New Haven, CT) and extracted using
Geneclean II (Bio 101, La Jolla, CA) .
Library Screening
A unidirectional lambda UniZap XR cDNA library was constructed by
Stratagene using oligo dT priming and poly(A)+ RNA purified from L8E63
myotubes. XL-1 blue cells were infected with the recombinant lambda
phage. Replica plaques were made on nitrocellulose filters previously
treated with 10 mM IPTG. The filters were blocked with TBST containing
2% gelatin for 2-3 h. Mouse monoclonal H36-05 antibody and alkaline
phosphatase conjugated goat anti-mouse IgG were used to detect H36-05
protein in the plaques. Immunoreactive plaques were visualized with BCIP
and NBT. To identify additional H36 cDNA clones, the phage library was
reprreened with a 293-bp PstI fragment of the 5'-end of clone H36-05B,
originally selected using H36-05 antibody. The fragment was purified and
labeled as indicated above. A total of ti3 x 106 plaques were screened.
Isolation and Cloning the S'-end ofH36-a7cDNA
Single strand cDNA was synthesized using 1 pg poly(A)' RNA purified
1. Abbreviations used in this paper: BCIP, 5-bromo-4-chloro-3-indolyl-
phosphate; CSAT, cell surface attachment; DRG, dorsal root ganglion;
GAP, glycine/alanine/proline; MHC, myosin heavy chain; NBT, nitroblue
tetrazolium; PCR, polymerase chain reaction; IPTG, isopropyl ß-D-thio-
glucopyranoside; TBST, tris buffered saline, Tween-20.
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from L8E63 myotubes, AMV reverse transcriptase (15 U/pg RNA; Pro-
mega Biotec, Madison, WI) and 0.5 pg of20-mer antisense primer (3'-GCT
GTCGGTGATGGAGTAAA-51 selected from the 5'-end ofclone H36-05E,
extracted with phenol/chloroform, precipitated with ethanol, and resus-
pended in 20 ;41 of water. 2 pl ofcDNA were amplified in polymerase chain
reaction (PCR) buffer (50 mM KCI, 1.5 MM MgC12, 100 pg/ml BSA, and
10 mM Tris-HCI, pH 8.4) containing 2 pM ofa 64-fold combination of 18-
met sense primer and 0.1 /AM 20-mer antisense primer, 250 IiM each of
dATP, dCTP, dTTP, and dGTP, and 1.25 U/50 pl reaction mixture of Taq
polymerase (Ampli Taq; Perkin-Elmer/Cetus, Norwalk, CT). The 20-mer
antisense primer was the same as that used for synthesis of the single strand
cDNA and the 18-mer sense primer mixture represented a 64-fold redun-
dancy coding the amino-terminal sequence (FNLDVM) of purified H36
protein:
5'-TTCAACCTGGACGTGATG-3'
T TT C T C
The PCR sample was cycled 30 times at 94°C for 2 min, 52°C for 1.5 min,
and 72°C for 3 min. The PCR product was separated on an 0.8% low melt
agarose gel, and the544-bp PCR fragment was cutout, purified usingGene-
clean II, and cloned using the dTtailed vector system described by Marchuk
et al. (1991). 1 ;ig of pBluescript plasmid digested with EcoRV was incu-
bated with 1 U Taq polymerase in 20 pl PCR buffer containing 2 mM dTTP
for 2 h at 70°C. The dTtailed plasmid was purified with phenol/chloroform
followed by ethanol precipitation and ligated with the purified PCR frag-
ment using T4 DNA ligase. XL-1 cells were transformed with the ligation
product, plated on X-gal, and white colonies were selected. The deoxynu-
cleotide primers were synthesized using an ABI 380B DNA synthesizing
machine and the amino-terminal sequence of the H36 protein was deter-
mined by the modified Edman procedure, using an ABI 477 pulse liquid
phase sequenator, at the University of Illinois Genetic Engineering Facility
(Urbana, IL).
DNA Sequencing
pBluescript SK-, rescued from lambda UniZap XR positive clones de-
tected by immunoscreening, were sequenced by the dideoxy chain termina-
tion method (Sanger et al., 1977) using [a-5351 dATP (1,000 Ci/mmol,
Amersham Corp.). The nucleotide sequences of independent subclones of
unidirectional deletions of clones 05A, 05B, and 05E, made with Exo/
Mung Bean nuclease (Henikoff, 1984; Stratagene, La Jolla, CA), were de-
termined. The cloned PCR fragment was sequenced from both ends. Anal-
yses of the nucleotide and amino acid sequences were performed using
DNASTAR, MacVector, and the University ofWisconsin Genetics Compu-
ter Group software, version 7.
Antigen Cross-linking Protocol
L8E63 cells, plated on 60-mm dishes and grown for 3 d, were reacted with
mAbs H36, 026, or A5. H36 and 026 antibodies react with purified H36
protein and H36 on live cells; A5 reacts with a non-crossreacting cell sur-
face protein (Lee and Kaufman, 1981). Rabbit antimouse immunoglobulin
(Jackson Immunoresearch) was added as secondary antibody. Cells were
washed three times with cold Dulbecco's PBS and once with cold buffer B
(100 mM KCI, 3 MM MgC12, 1 mM CaCIZ, 300 mM sucrose, and 10 mM
Hepes, pH 6.9). The cells were extracted with 1 % Triton X-100 in buffer
B for 5 min, on ice, and the supernatants were collected . The residue was
solubilized in 1% SDS. The effect of cross-linking H36 with antibody on
its extractability in Triton X-100 was determined by immunoblot analysis.
Extracellular Matrix
Protein A nity Chromatography ffi
ofH36-a7 Integrin
L8E63 myotubes and myoblasts on three 100-mm dishes (-1.5 x 101 nu-
clei) were collected using a rubber policeman and extracted twice for 30
min, at 4°C, with 150 ml octylglucoside buffer (200 mM octyl-ß-D-gluco-
pyranoside, 1 mM PMSF, and 100 mM Tris-HCI, pH 7.4). The extracts
were adjusted to a final concentration of 2 mM MnS04 and passed through
a 1-ml column of Affigel-10 (Bio-Rad Laboratories) conjugated with either
1.08 mg purified Engelbreth-Holm-Swarm sarcoma laminin (provided by
Ms. B. Rainish (University ofIllinois, Urbana, IL) and Dr. A. F. Horwitz
(University of Illinois, Urbana, IL)), 1.10 mg purified plasma fibronectin
(provided by Mr. K. McDonald (University of Illinois, Urbana, IL) and Dr.
A. F. Horwitz), 1.94 mg type I rat tail collagen (Sigma Chemical Co., St.
Louis, MO) or 1.68 mg type IV calf skin collagen (Sigma Chemical Co.).
645The columns were washed with buffer B (50 mM odyl-/3-D-glucopyrano-
side, 1 mM MnSO4, 50 mM Tris-HCI, pH 7.4), followed by buffer B con-
taining 250mM NaCl and eluted with 50 MM octyl-ß-D-glucopyranoside,
10 mM EDTA, 50 mM Tris-HCI, pH 7.4 . The eluate was adjusted to 20
MM MgCIZ, concentrated using a Centricon-30 tube (Amicon Corp ., Dan-
vers, MA) and analyzed by immunoblotting .
Results
Preparation ofL8E63Myotube cDNA Library
Poly(A)+ RNA was purified from L8E63 myotubes using
oligo dT cellulose affinity chromatography. The poly(A)+
RNA migrated in a 1% agarose, 2.2 M formaldehyde gel as
a broad band with a heterogeneous mobility corresponding
to -0.5 to 10 kb. This RNA promoted, in a stoichiometric
fashion, the synthesis of protein in an in vitro wheat germ
system . The poly(A)+ RNA also promoted the synthesis of
H36 upon injection into Xenopus oocytes, indicating that the
specific mRNA of interest was present in the mixture .
A myotube unidirectional cDNA library was constructed
Figure 1. Detection ofH36 pro-
tein by immunoblot analysis .
H36 protein (H36), purified
from new born rat hindlimbs
by immunoaffinity chromatog-
raphy, was resolved on 8.0%
polyacrylamide SDS gels un-
der reducing (+) and non-
reducing (-) conditions. (A)
The proteins were transferred
to nitrocellulose and then im-
munoblotted with mousemAb
05 . 15 jug of protein in an
L8E63 myotube lysate (mt)
were also analyzed by immu-
noblotting . As asmall amount
of H36 mAb elutes from the
affinity column, purified H36
antibody (H364b)wasrun as a
control . Purified H36 protein
was also electrophoresed in
the lanes marked SP2/0, and
immunoblotted with culture
fluid from the SP2/0myeloma
cells used to prepare the 05
hybridoma . These controls
show the bands that develop
due to the binding of secon-
dary antibody to H36 anti-
body present in the purified
H36protein . 05 antibody iden-
tified bands at 120,000 and
70,000 D in the unreduced
purified H36 complex and at
35,000 D and 100,000D upon
reduction . (B) To confirm
that the proteolytic cleavage of
the 120,000-D protein yields
the 100,000-, 70,000- and 35,000-D fragments, affinity purified H36 was electrophoresed under nonreducing conditions, the 120,000-,
100,000-, and 70,000-D bands were cut out, incubated with 100 mM DTT, electrophoresed again on 8% polyacrylamide SDS gels and
immunoblotted with 05 antibody . The results demonstrate the origin of the fragments from the 120,000-D protein . (C) Cleavage at either
or both of the proteolytic cleavage sites RRQ and RRRRE (determined by sequence analysis) completely accounts for the generation and
sizes ofthe fragments detected with the 05 antibody . Theapparent molecularweights of prestained 0-galactosidase (116,000), phosphorylase
b (106,000), bovine serum albumin (71,000), ovalbumin (44,000), and carbonic anhydrase (28,000) are indicated .
RRQ RRRRE
NH 2
￿
120KD
￿
protein
￿
,Ilr
￿
000H
100KD fragment
70KD fragment
35KD fragment
protease cleavage sites
05 antibody recognition site
The Journal of Cell Biology, Volume 117, 1992
￿
646
in lambda UniZap XR (Stratagene) using the poly(A)+
RNA and oligo dT priming. The original library contained
1.4 x 10 7 primary plaques and was subsequently amplified .
ThecDNA inserts were excised by coinfection of XL-1 blue
cells with the lambda phage and VCSM13 helper phage . The
phagemid was isolated and used to transform XL-1 blue
cells . The pBluescript SK- plasmid was purified and linear-
ized using Xhol . Translationally active RNA was tran-
scribed, capped and microinjected into Xenopus oocytes .
Immunofluorescence ofH36, detected after injectionof three
independent RNA preparations, indicated that the cDNA of
interest was contained in thecloned library (data notshown) .
Isolation ofH36cDNA Clones and Sequence Analysis
Since the original H36 mAb does not readily react with the
denatured protein, it was necessary to prepare additional an-
tibodies to useto screen the lambda expression library . H36
protein isolated from 5-d-old rat pups by immunoaflnity
chromatography was used as the immunogen . One of theFigure 2 . Crosslinking H36 protein on the cell surface with antibod-
ies alters extractability by detergent . L8E63 cells were grown for
3 d, reacted with mAbs 026, A5, or H36. The cells were then re-
acted with rabbit antimouse immunoglobulin and extracted with
1% Triton X-100. The supernatants (S) and detergent insoluble cell
pellets (P) were collected, subjected to SDS-PAGE under reduced
conditions, followed by immunoblot analysis using 05 antibody . In
the absence ofprimary antibody (No 1°) or primary and secondary
antibodies (No 1°, No 2°) most H36 protein detected with 05 anti-
body is solubilized (S) . Cross-linking with 026 and H36 antibodies
promotes association of H36 protein with the cytoskeleton, render-
ing it insoluble in Triton X-100 (P) . A5 antibody does not react
with H36, but with another protein on the L8E63 cell surface (Low-
rey and Kaufman, 1990), and therefore does not effect extraction .
mAbs, denoted 05, immunoblotted with the 120,000-D pro-
tein in the purified H36 preparation and in lysates prepared
from L8E63 cells, under unreduced conditions (Fig. 1 A) .
The additional high molecular weight bands seen in the im-
munoblot of unreduced purified H36 protein are due to the
reaction of secondary antibody with H36 mAb that elutes
during the immunoaffinity purification . When the H36 pro-
tein was in its reduced state, 05 antibody identified bands
at 35,000 D and 100,000 D in immunoblots . The 35,000-D
band was most prominent upon analysis of the reduced
purified H36 protein whereas the 100,000-D protein pre-
dominated in the immunoblots of the reduced myotube ly-
sate . A 70,000-D protein in the unreduced preparation of
purified H36 also reacted with the 05 antibody. Two-
dimensional polyacrylamide gel analysis demonstrates that
the 35,000-, 70,000-, and 100,000-D proteins originate from
the proteolytic cleavage of the unreduced 120,000-D protein
(Fig . 1, B and C) . In this experiment, purified H36 protein
was electrophoresed under non-reducing conditions and the
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120,000-, and 100,000-, and the 70,000-D proteins were iso-
lated, reduced and rerun . As shown in Fig . 1, B and C, reac-
tivity with one mAb (05) and two proteolytic cleavage sites,
account for all the peptides detected in the immunoblots . As
will be discussed, sequence analysis confirms the location of
these protease cleavage sites. To further demonstrate reactiv-
ity of05 antibody with H36 we cross-linkedH36 protein on
L8E63 cells using H36 antibody followed by rabbit anti-
mouse antibody. Normally, most H36 is readily extracted
from the cells by Triton-X 100, however, cross-linking with
antibody promotes its association with the cell cytoskeleton,
rendering it relatively unextractable (Lowrey and Kaufman,
1989) . As shown in the immunoblot in Fig . 2, crosslinking
H36 protein with anti-H36 antibody specifically alters the
extractability of the protein reactive with 05 antibody. Like-
wise, 026 antibody also reacts with H36 and also promotes
its association with the cytoskeleton . Cross-linking with an-
tibodies reactive with proteins not in the H36 complex, for
example A5, does not alter the association ofH36 with the
cytoskeleton nor its extractability .
The lambda Unizap XR cDNA library was screened with
the 05 antibody. Three independent cDNA clones were iso-
lated from assays of -5 x 105 plaques . The pBluescript
SK- plasmids were isolated as indicated above and the sizes
of the inserts were determined by cleaving with EcoRI and
XhoI and electrophoresis in 0.8% agarose gels . The sizes of
the three cDNA inserts, 05A, 05B, and 05C, are 2.5, 2.3,
and 1.8 kb, respectively (Fig . 3) . Nucleotide sequence anal-
ysis indicates that these cDNAs encode the same protein .
The 2.3-kb insert codes for an 80,000-D fusion protein,
(determined by immunoblotting) of which, -15,000 D is
ß-galactosidase.
A PstI fragment representing 293 by from the 5'-end ofthe
05B clone was prepared, labeled by random primer label-
ing, and used to screen the library for a full-length cDNA
insert . The05EcDNA clone was isolated and the size of the
gene insert was determined to be 3.4 kb . As a full-length
cDNA insert could not be identified in the library, a 544-bp
cDNA fragment overlapping the 05E clone and encoding the
amino terminal end of the protein was synthesized, cloned,
and sequenced .
DNA sequencing was performed by the dideoxy chain ter-
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Figure 3. Sequencing strategy
of H36-05 cDNA and PCR
clones . The hatched bar repre-
sents the full length H36
mRNA, the open bar repre-
sents the 544-bp PCR frag-
ment and the closed bars
indicate the H36-05 cDNA
clones selected from the li-
brary. The direction and ex-
tent of sequencing the 3'- and
5'-ends of the cDNAs, deletion
subclones, and oligonucleo-
tideprimed internal sequences
are indicated by the arrows .mination method using Bluescript SK primer for the 5'-end
and the T7 primer for the 3'-end as well as synthetic oligonu-
cleotide primers. Subclones of clones 05E, 05B, and 05A
which have 3'- or 5'-overlapping deletions were made using
Exo/Mung bean nuclease. The sequence ofthe 3.4-kb cloned
cDNA insert and the cloned 544-bp PCR fragment were de-
termined in both directions as indicated in Fig. 3. The 3,774
nucleotide sequence includes one open reading frame encod-
ing 1,106 amino acids, a TAA translation stop codon, and a
stretch of453 nucleotides comprising the 3'-untranslated re-
gion that contains the poly A tail (Fig. 4). The presumed
polyadenylation recognition sequence, ATTAAA, beginning
at nucleotide 3,735, in slightly altered but identical with that
reported for the myogenic regulatory gene MRF4 (Rhodes
and Konieczy, 1989). Hydrophobicity analysis (Kyte and
Doolittle, 1982) of the deduced amino acid sequence pre-
dicts a single membrane-spanning region at amino acid
residues 1007-1029. There are four potential glycosylation
sites (asparagine-X-ser/threonine) in the extracellular do-
main of H36 and three calcium binding sites which satisfy
the consensus sequence D-X-D/N-X-D/N-G-X-X-D (Van El-
dik et al., 1982). The molecular weight of the protein
deduced from its inferred amino acid composition is 120,957
D. Addition of carbohydrate to the four potential glycosyla-
tion sites, each "2,500 D, would result in a glycoprotein
with a mass of 131,000. The sum of the masses of the frag-
ments generated upon reduction and detected in immuno-
blots is ^128,000-135,000 D.
H36 Is a Novel Integrin Alpha Chain
Alignment and comparison of the inferred H36 amino acid
sequence (Fig. 5) demonstrates that H36 shares extensive
structural homologies with integrin alphachains (Tamura et
al., 1990; Albelda and Buck, 1990; Hemler, 1990; Hum-
phries, 1990) that include : (a) The GFFKR sequence (res-
idues 1032-1036) in the cytoplasmic domain of H36 is iden-
tical with the characteristic of all reported integrin alpha
chains with the exception of the Drosophila PS2 protein in
which the lysine is replaced by an asparagine residue
(Bogaert et al ., 1987); (b) the single membrane-spanning re-
gion and single cytoplasmic domain inferred from hydropho-
bicity analysis of the H36 sequence are consistent with that
found in all other integrin alpha chains ; (c) there is extensive
conservation of the locations of cysteine residues in H36 and
the other integrin a chains. 16 of 22 cysteines identified in
H36 align with those in all other alpha integrins and eighteen
of the twenty-two cysteines are at conserved positions in H36
and the non-I domain alpha chains ; (d) H36 has a pro-
tease cleavage recognition site at residues 882-886 in the ex-
tracellular domain that satisfies the consensus sequence,
K/RRE/D, identifiedin other integrin alpha chains (de Cur-
tis et al., 1991). (e) the five conserved repeats of glycine/ala-
nine/proline (GAP) found in the amino-terminal half of all
the other integrin alpha chains are also present in H36.
Using DNASTAR, a range of homologies was found be-
tween H36 and the other integrin alpha chains (Fig. 5) . Se-
quence alignment shows that H36 shares 24% identity in a
1,008 amino acid overlap with a5 integrin (Argraves et al.,
1987), 31% identity in a 1,008 amino acid overlap with the
«IIb chain (Poncz et al., 1987) and 35 % identity in a 1,052
amino acid overlap with galactoprotein b3 chain (Tsuji et al .,
1990) as well as the other basic features cited above. In
general H36 exhibits greater homology with those integrin
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alpha chains that have the characteristic protease cleavage
site compared with those that contain the I domain.
The greatest homology of the deduced H36 sequence is
with humana6 integrin (Tamura et al., 1990) (Fig. 5). There
is 47 % identity in a 1,047 amino acid overlap and the trans-
membrane domains of these two proteins are even more
similar (70 % identity). Differences between H36 and the hu-
man a6 chain include : (a) H36 has a unique cytoplasmic do-
main comprised of 77 amino acids. With the exception ofthe
GFFKR consensus sequence, the cytoplasmic domain of
H36 is as divergent from those of the other integrin alpha
chains as they are from each other ; (b) The protease cleavage
site in the extracellular domain of H36 (RRRRE, residues
882-886) is distinct from that in human a6 (RKKRE).
Cleavage at this site yields the 100,000-D fragment detected
with the 05 antibody in immunoblots and a smaller frag-
ment, "28,000 D, which would not be detected by this anti-
body. Such a peptide was detected using an antiserum reac-
tive with purified H36 protein (data not shown). There is a
second potential proteinase cleavage site (RRQ) at residues
575-577 in H36. Cleavage here generates the 70,000-D frag-
ment and cleavage at both sites yields the 70,000- and
35,000-D fragments detected with H36-05 antibody (Fig.
1) . Two additional potential dibasic cleavage sites, KK and
KR, one on each side of the RRRRE site, couldprovide het-
erogeneity in the cleavage products; (c) There are ten inser-
tions in the H36 amino acid sequence, including one of seven
amino acids, and one double and seven single amino acid de-
letions. The homology ofthe humana6 amino acid sequence
with other integrin alpha chains is between 18-26% identity
whereas the homology between «6 chains from human and
chick is 73% (de Curtis et al ., 1991). Thus the H36 and a6
are amongstthe mostclosely related integrin alphachains, yet
they are distinct. We conclude that H36 is a novel integrin
alpha chain. In keeping with the nomenclature of the alpha
integrin chains, we suggest H36 be designated 0.
1136-cx7ls Associated with Integrin 01 Chain
and Binds to Laminin
To determine which integrin beta chain is associated with
1136-a7, rabbit antisera raised against the 01, 03, 04, 05,
or 06 cytoplasmic domains were reacted in immunoblots
against the purified H36 complex. Two independently pro-
duced antisera specific for the cytoplasmic domain of 01 and
one monoclonal anti-01 antibody (014-1) identified the inte-
grin 01 chain in the H36 complex: the other antisera were
negative (Fig. 6 A) . Immunoblots using extracts prepared
from myotubes also indicate integrin 01 chain in these lysates
(Fig. 6 B) .
The extensive homology between H36-a7 and a6 inte-
grins and the binding of a6ß1 to laminin suggested that H36-
a701 also might bind this extracellular matrix protein . The
heterodimer extracted from L8E63 myotubes selectively
bound to a laminin column and was eluted with EDTA (Fig.
6 C) . There was much less binding of 1136-a7 to fibronectin
and no association with types I and IV collagen was detected.
The H36-a7 that bound and eluted from the laminin column
was complexed with 01 integrin (data not shown). These
results were confirmed by immunoblots of the material that
did not bind to each extracellular matrix protein column .
Immunofluorescence localizations using anti-1136 and
anti-01 antibodies indicate both coincident and distinct dis-
tributions of these determinants on myoblasts and myotubes.
648Figure 4. Nucleotide sequence
and deduced amino acid se-
quence of H36-a7. The DNA
sequence of H36-a7 and the
corresponding open reading
frame of 1106 aminoacids are
shown. The single transmem-
brane domain inferred from
hydrophobicity analysis is in-
dicated by a solid line. Three
potentialcalciumbindingsites
in the amino-terminal half of
the molecule are enclosed in
Open boxes.Theconservedre-
peatsofglycine/alanine/proline
(GAP) found in theaminoter-
minaihalf of H36-a7 areindi-
catedinthedashedboxes. Four
potential asparagine glycosyl-
ationsites are indicatedby as-
terisks (*). The two shaded
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boxes mark the consensus se-
quences of potential protease
cleavage sites. As discussed,
cleavage at these sites could
generate the polypeptides de-
plcted in Fig. 1 C. The pre-
sumedpolyadenylation recog-
nition sequence, ATTAAA, is
indicated in bold. DNASTAR
Mapseq, and MacVector
Protein Subsequence, and
Protein Toolbox were used
in this analysis. The se-
quence data are available
from EMBL/GenBank/DDJB/
Swiss-Prot under accession
number X65036.
TTCAACCTGGATGIGATGGGTGCCATACGCAAGGAGGGAGAACCTGGCAGCTTATTCGGCTITICGGTGGCCCTACACCGACAATTACAGCCCCGACCCC 100
F N L D V M G A I R K E G E P G S L F G F S V A L H R Q L Q P R P Q
AGAGCIGGC'1GCTGGT000TGCCCCCCAGGCCCTGGACTCTTACCCGGACAGCAGGCAAATCGCACATGGGAGGCCTCTI7GC7R,GMCCTGA000TAGA 200
S W L L Q A L D S Y P D S R Q I A H G R P L C L S L S L E
GGAGACAGACTGCTACAGAGTGGACATCGACAGGGGAGCTAATGTGCAGAAGGAAAGCAAGGAGAACCAGTGGCTGWAG7CAGCGTGCGACCGAGGGAG 300
E T D C Y R V D I D R G A N V Q K E S K E N Q W L G V S V R P R E
TCCGGGGGCAAGG17G7TACCTGTGCACA000ATATGAGTCTCGACAGAGAGTGGACCAG[,TPI7GGAGAC7CGAGATGTGATTGGTCGT'IGCTITGTGC 400
8 G G X V V T C A H R Y E S R Q R V D Q V L E T R D V I G R C F V L
7GA000AGGACCTGGCCATCCGTGATGAGT7GGATGGTG(.GGAGTGGAAGIRCTGPGAAGGGCGCCCCCAGGGCCACGAACAAITMG7TCTGCCAGCA 500
S Q D L A I R D E L D G G E W K F C E G R P Q G H E Q F G F C Q Q
GGGCACAGCTGCCACCTTCTCCCCCGACAGCCACTACCTCA7R7R7 _C`(ÇçAGGAACCTATMCTGGAAG(:GCACA000AGC+G7C.GAGC7CTG7GCG 600
G T A A T F S P D S H Y L I F "G A P " G T Y N W K G T A R V E L C A
CAGGGCTCG7CGGACCTGGCACAGGTGGATGATGGGCCCTACGAGGCGGGGGGCGAGAAGGACCAAGACCCCCGTCC7TCACCGGTCCC'IGCCAACAGCT 700
Q G S S D L A Q V D D G P Y E A G G E K D Q D P R P S P V P A N S Y
ACCTTGGT7TCTCCATTGASTC7GGGAA000TC7CATGCGCTCAGAAGAGCTGAGTPIT37GGCAGG_G_GC_CCCACGTGCCAACCACAAAGGGGCIG7GGT 600
L G F S I D S G K G L M R S E E L S F V A G A p R A N H K G A V V
CAT7C7G000AAGGATAGTGCCAGCCGCCTGATTCCTGAGG7'I'G'Ir,C743747TGGGGAGCGCC7GACCTC7GGC771GGCTACICCCT0007GTGAC7GAC 900
I L R K D S A S R L I P E V V L S G E R L T S G F G Y S L A V T
C7CAACAGTGAT000TGGGCAGACCTGATrG7GGGTGCTCCCTACTTCTIR'GMCGCCAAGAAGAAC7TGGAGGAGCCGTGTAIGTGTACATGAACCAGG 1000
W L I V Ç. . A_ .P- Y F F E R Q E E L G G A V Y V Y M N Q G
GTGGCCA7TGGGCAGATATCTCTCCTCTCCGACTC7G7GGCTCCCCTGACTCCATG~GATCAGTITGGCTGTACTGGGGGACCTCAATCAAGATGG 1100
G H W A D I S P L R L C G S P D S M F G I S L A V L G
CTTCCCAGACATTGCTGTAGGAGCTCCCTITGATGGAGATGGGAAAGTCTITATCTATCATGGGAGCAGCCTGGGGGTGGTCACCAAACC7TCACAGGTG 1200
( I A V -q_. A__ P~ F D G D G K V F I Y H G S S L G V V T K P S Q V
CTGGAGGGTGAGGCTGTGGGTATCAAGAGCTI7GGTSACTCCCTG"ICTGGTGGCCTGGATGTGGACGGAAATCACTACCCGGACCTGC7RG7G',GCTCCC 1300
LEGEAVG1KSFGYSLSGGL IDVDGNHYP~ LLVGSL
TGGCTGATACTGCTGCTCTGTfCAGGGCCAGACCTGTTCTACATGTCTCCCAAGAAATCTXA'ITGATCCAAGAGCCATCGATCTGGAACAGCCCAACTG 1400
A D T A A L F R A R P V L H V S Q E I F I D P R A I D L E Q P N C
TGCCGACGGACGCTTGGTC7GCGTGCACGTAAAGGTCTGTITCAGTTATGTrGCTGTGCCCAGCAGCTACAGCCCTATfGTGGTCCTAGATTTTATGTGTFA 1500
A D G R L V C V H V K V C F S Y V A V P S S Y S P I V V L D Y V L
GA'IGGGGACACAGACCGGAGGCTCCGGGGCCAGGCTCCACGTG7GACTT7CCCGGGCCGAGGCCCGGATGA7CTCAAGCATCAGTCCICGGGCACCGTGT 1600
D G D T D R R L R G Q A P R V T F P G R G P D D L K H Q S S G T V S
CGTTGAAGCACCAACA7GACAGAGTC7GTGGAGACACATGTGTPCCAGCTGCAGGAAAACGTAAAGACAAGCTA000GCCATTG7GGTGACCCTGTCATA 1700
L K H Q H D R V C G D T C V P A A G K R K D K L R A I V V T L S Y
TGGTCTCCAAACCCCTCGATTAAGGAGGCAAGCGCCTGACCAGGGGCTCCCCC77G7GGC"1G ATCCTCAACGCTCACCAGCCCAGTACACAGAGGACf 1800
G L Q T P R L A P D Q G L P L V A G I L N A H Q P S T Q R T
GAGATCCACTfCCTGAAGCAAGGCTGTGGTGACGATAAGATCTGTCAGAGCAACC7CCAGCT743TGCAGGCCCAG7TCMTTCCCGGATCAGCGACACAG 1900
E I H F L K Q G C G D D K I C Q S N L Q L V Q A Q F C S R I S D T E
AGTTCCAGGCIC7GCCCAMGA7CTGGATGGGACCGCCCTGlT7GCGCATGGCGGGCAGCCATTCATAGGCCTGGAGCTGACAGTCACCAACCTGCCCTC 2000
F Q A L P M D L D G T A L F A H G G Q P F I G L E L T V T N L P S
TGACCCAGCCCGGCC7CAGGCAGA'fGGGGATGATGCTCATGAAGCCCAGCTCCTGGCCACCCfCCCAGCCTCTCTPCGATAC7C000AGTCCGCAC7CTG 2100
D P A R P Q A D G D D A H E A Q L L A T L P A S L R Y S G V R T L
GACTCTGTGGAGAAGCCGCTCTGCCTGTCCAACGAGAATGCCTCTCATGTCGAGTGTGAGC7CGGGAACCCTATGAAGAGAGGCACTCAGGTCACC7TTT 2200
D S V E K P L C L S N E N A S H V E C E L G N P M K R G T Q V T F Y
ACCTCA7CCTCAGCACCrCTGGAATCACCATTGAGACCACAGAGC-0ACGA7CAGTGAGCAGGACCTGCAT000GTCTC 2300
L I L S T S G I T I E T T E L K V E L L L A T I S E Q D L H P V S
CG7'rCGGGCTCA7CTCTTCA7TGAA1'FGCCGCTGTCCATITCAGGGGTGGCCACTCCTCAGCAACTCTIC7R'CTC7GGCAAGG7GAA000GGAGAGCGCC 2400
V R A H V F I E L P L S I S G V A T P Q Q L F F S G K V K G E S A
ATGCGG7CMAGAGGGACGTGGGCAGCAAGGTCAAGTACGAGGTCACGG7CTCCAATCAAGGCCAGTCACTCAATACTCTGGGCTOTGCCITCCTCAACA 2500
M R S E R D V G S K V K Y E V T V S N Q G Q S L N T L G S A F L N I
TCATGTGGCCCCATGAGATCGCCAATGGGAAATCCC7GTTGTACCCCATGCGGGTGGAGCTGGAGGGIGGACAGGGGCCTGAGAAGAAAGGGATCTGCTC 2600
M W P H E I A N G K W L L Y P M R V E L R G G Q G P E K K G I C 3
CCCAAGACCCAACATCC7CCACCTGGATGTGGACAGCAGGGATAGGAGGCGGCGAGAGCTGGGGCAGCCGGAGCCTCAGGAGCCTCCAGAGAAGGTGGAA 2700
P R P N I L H L D V D S R D " ç z :A:-':~AJ L`: L G Q P E P Q E P P E K V E
CCTAGCACATCTIGGTGGCCAGTGTCCTCCGCTGAGAAGAGAAACGTGACCTIGGACTGCCCAGGCACGGCCAAGTGTGTGGTATTCAGCTGCCCACTCT 2800
P S T S W W P V S S A E K R N V T L D C P G T A K C V V F S C P L Y
ACAGGTI'rGACCGTGCAGCCGTGCTPCATGTCFGGGGCCGCCTCTGGAACAGCACC74'TCTGGAGGAGTACA7GT000TGAAGTCCCIGGAGGTGATCGG 2900
S F D R A A V L H V W G R L W N S T F L E E Y M S V K S L E V I V
CCGAGCCAACATCACAGTGAAATCCTCCATTAAGAAC77'GCTGCTCAGAGATGCATCCACAGTGATCCCAGTGATGGTATAC7TGGACCCGGTGGCT43M 3000
R A N I T V K S S I K N L L L R D A S T V I P V M V Y L D P V A V
GTTGCAGAAGGAGTCCCCTGGTGGGTCAWCTCCTGGCGGTGCTGGCTGGGC7GCTAGTACTGGCCCTGCTGGTGCTGCTGCMTGCAAGC7GGGA= 3100
V A E G V P W W V I L L A V L_A G __L L V L A L L V L L L W K L G F F
TCAAGCGGGCGAAGCACCCTGAGGCCACTGTACCCCAGTACCACGCAGTGAAGATCCTM000AAGACCGGCAGCAGTICAAGGAGGAGAAGACAGGCAC 3200
K R A K H P E A T V P Q Y H A V K I L R E D R Q Q F K E E K T G T
CATFCAGAGGAGTAACTGGGGCAATTCCCAGTGGGAGGGCTCCGACGCACACCCTATCC7GGCTGCCGACTGGCACCCTGAGTTGGGTCC7GATGGACAT 3300
I Q R S N W G N S Q W E G S D A H P I L A A D W H P E L G P D G H
CCTGTGTCAGTCACTGCCTAACTTCTCCTGTCCCAAGCCAGCCTCTGGGTWCTTCCACCCTITCCCAAGAIr,GCTCTI'rGC,GGGTr,C GATAGT3GAGT 3400
P V S V T A
P.GGTIGCPGGCTTCATGTPGAMTAAGGCAGGTWTGCTI7C'ICAGGGGCACAGATCTITCCCACCGTGAGMCCACCCCTICCCA7CT'MTCCGTACAA 3500
7GC7G7GAGACA000GGCAIGGC7GGAAGGACAGOCA7GACC7GGTGCAGGATGGAGMGM000GTACTGAGC'iI-CCTCTCWACCCACCC7GTAAGAC 3600
CG7CTT000CAAAGTGCCTTAGACAGAGGGTCAGGGAAGAGATCGTGTCACTGTCTCAGGGGCCCTTCCCTCCTAAGTC~CTG7GCTC7GGCCrrAG 3700
MTGCIGTACCAGCCCAGCGGATCT'IGTCTATTT,TTAAA4AGTA1T17`GACMT 3774a
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3Figure 6. Immunoblot of 01
integrin in the purified H36
complex and myotube lysates .
Immunoaffinity purified H36
and L8E63 myotube (mt) ly-
sate were resolved by 8.0%
polyacrylamide gel electro-
phoresis under nonreducing
(-) and reducing conditions
(+) and transferred onto ni-
trocellulose . (A) Immunoblot
using mouse monoclonal 014-1
anti-ßl antibody. (B) Immu-
noblot using rabbit antiserum
raised against the cytoplasmic
domain of chick integrin 01
chain . These results demonstrate 01 integrin in the purified H36 complex ; antisera against 03, 04, 05, and 06 integrins were negative .
(C) Immunoblotting demonstrates that H36-a7 selectively binds to laminin . L8E63 cells were extracted with octylglucoside, the extract
was passed through an Affigel-10 column conjugated with laminin and the bound material was eluted with EDTA as described in Materials
and Methods. The fraction eluted from the laminin column (Ln) and the original myotube lysate (mt) immunoblotted identically with 05
antibody while fractions from fibronectin and type I and IV collagen columns did not .
In mixed cultures of myoblasts and fibroblasts prepared from
newborn thigh, localization of H36-a7 is restricted to the
myogenic cells whereas ßl integrin is found on both cell
types (Fig . 7, A-E) . The greatest coincident localization of
the two chains on replicating myoblasts appears at the pe-
riphery of the cells, although for the most part their distribu-
tions are disparate, especially on the upper surface of the
cells . Coincidence in staining of H36-a7 and ßl is most evi-
dent on the attached surface of fusing myoblasts (Fig . 7, F
and G) and newly formed myotubes, especially in those
areas where localization of the alpha chain is most linear
(Fig . 7,H and I) . Many myotubes, especially those that are
well developed, are largely devoid of ßl staining, in contrast
with H36-a7 which is strongly evident at this stage of devel-
opment (Fig. 7, D and E) . This decrease in ßl localization
on myotubes was seen with five distinct antibody prepara-
tions, two reactive with the cytoplasmic domain and three
with extracellular determinants . Immunoblot analyses con-
firm that an increase in H36-a7 and decrease in ßl accompa-
nies myogenic differentiation (Fig . 8) . An antiserum reactive
with the cytoplasmic domain of ßl was used in the experi-
ment shown and identical results were obtained using two ad-
ditional antisera reactive with the ßl chain . Since integrins
are assembled as heterodimers, the absence of more com-
plete coordinate localization of H36-a7 and ßl obtained
using antibodies that react with extracellular determinants
suggests that the H36-a7 may associate with more than one
form of beta chain . These results also indicate that the ex-
pression of H36-a7 and ßl integrins are developmentally
regulated .
Developmental Regulation ofH36-a7
mRNA Expression
To determine whether the expression of H36-a7 mRNA is
developmentally regulated, poly(A)+ RNAs were purified
from L8E63 cells at different stages of development and ana-
lyzed by northern blots using random primer labeled clone
05B as probe . H36-a7 mRNA corresponding in size to 4.0
kb was detected and appeared identical in size in myoblasts
and a quantitative increase occurs upon terminal differentia-
tion . This increase appears to approximately coincide with
the onset of myogenin expression (Fig . 9) and is consistent
with immunofluorescence detection of the H36 protein
(Kaufuran et al ., 1985) and immunoblots usingH36-05 anti-
body (Fig . 8) . Myosin heavy chainmRNA is expressed rela-
tively late compared to the increase in H36-a7 mRNA .
The amount of H36-a7 mRNA detected in the develop-
mentally defective fu-1 mutant of L8E63 myoblasts is
markedly reduced (Fig . 10 A) and these cells also express
very little H36-a7 protein as determined by immunofluores-
cence photometry (Kaufuran et al ., 1985) . Expression of
H36-a7 mRNA was also found to accompany the develop-
ment of H36- myogenic precursor cells in the day 12 em-
bryonic limb bud into H36+ cells . Immunofluorescence in-
dicates that cultures prepared from embryonic day 12 rat
Figure 5. Alignment of H36-a7, u6, a5, av, cdIb, and c«4 integrin chain sequences . Alignment of the amino acid sequences of H36-a7
and the integrin alpha chains which have a characteristic protease cleavage site is shown . Thiscommon cleavage site (RRRRE, at residues
882-886 in H36-a7) and the homologous sites in the other chains are indicated in shaded boxes, as is a second potential cleavage site
(RRQ, at residues 575-577) in H36-a7. The sequence data of integrin alpha chains were obtained from the Swiss Protein database, version
17, with the following accession numbers : a5, fibronectin receptor (p08648) ; av, vitronectin receptor (p06756) ; ceRb, gplIb (p08514) ;
a4, VLA-4 (p13612) ; and a6 (Tamura et al ., 1990) . Paired alignments were initially done using the AAlign program ofDNASTAR and
theGAP program of University of Wisconsin Genetics Computer Group . The multiple alignment was obtained using the LINEUP program
from the Wisconsin Group . The amino acids conserved in all six integrin alpha chains are indicated in bold . The presumed calcium binding
sites are enclosed by boxes . The highly conserved sequence in the cytoplasmic domain, GFFKR, is indicated in the box with a dashed
line . These integrins all have a single cytoplasmic domain; each begins two residues to the amino terminal side of the GFFKR sequence
and each is distinct in length and composition .
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652Figure 8 . Expression of H36-a7 and 01 integrin during L8E63 cell
differentiation . Cell lysates prepared from L8E63 cells at different
stages of development (Days 2, 3, and 8) were electrophoresed in
8% polyacrylamide SDS gels under nonreduced (-) and reduced
(+ ) conditions andimmunoblotted using05mAband an antiserum
against the cytoplasmic domain of 01 chains . Fusion was evident
on day4and extensive by day 8of culture . Theamount of H36-a7
increases and 01 decreases during differentiation .
hindlimb buds do not initially express H36 or desmin but do
so upon serial passage in vitro (Kaufman et al ., 1991) . Like-
wise, H36-a7 mRNA was notdetected inRNA from passage
1 (PI) cells but was present in poly(A)+ RNA from P3 and
P4 cells (Fig . 11) . As will be discussed, activation of tran-
scription of the H36-a7 gene at this early stage in the myo-
genic lineage appears to be distinct from later stages of de-
velopment . The expression of H36-a7 mRNA also parallels
the conversion of IOTl/2 cells to myogenic cells . H36-a7
mRNA is not detected in IOTl/2 cellsbut it is present in myo-
tubes derived from myoblasts obtained by azacytidine treat-
ment or transfection of IOTl/2 cells with MRF4 (Fig . 10 C) .
Cell Specificity of H36-a7Integrin
Both hybridization analyses and immunofluorescence indi-
cate that the expression of H36-a7 is highly restricted and
developmentally regulated during the development of skele-
tal muscle . The detection of H36 was first reported to be
limited to cardiac and skeletal muscle that were grown in
vitro (Kaufman et al ., 1985) . It has since been used to iden-
tify cells at distinct stages in the myogenic lineage both in
vivo and in vitro (Kaufman and Foster, 1988 ; Kaufman et
al ., 1991) . As shown in Fig . 12, H36-a7 also is present in
adult skeletal muscle in vivo . H36-a7 has also been detected
by immunofluorescence on dorsal root ganglion cells in the
developing rat embryo (GeorgeWeinstein, M ., manuscript
submitted for publication) . As notedabove, H36-a7 integrin
canbe detected on myoblasts butnot fibroblasts in mixedcul-
tures of hindlimb cells (Fig . 7), in myogenic cells derived
from precursors (Kaufman et al ., 1991), andin myotubes de-
rived from IOTI/2 cells (Fig . 10 C), further indicating that
expression of this protein is highly selective . Northern blot
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Figure 9 Expressionof H36-a7 mRNA during L8E63 cell differen-
tiation . Poly(A)+ RNAs purified from L8E63 cells at different
stages of development were analyzed in northern blots using H36-
a7, myosin heavy chain (MHC) and myogenin labeled cDNA
probes . H36-a7 mRNA is detected in replicating myoblasts. Image
analysis of the autoradiographs indicates a 3 to 4-fold increase in
H36-a7 mRNA as the cells differentiate. By day 6, the myoblasts
had ceased replication (as determined by incorporation of BrdUrd
[Kaufman and Foster, 1988]), fusion was advanced, and MHC
mRNA was evident . Myogenin expression appears to precede that
ofMHC and to correspond with the increase in H36-a7 mRNA .
analyses demonstrate that H36-a7 mRNA is expressed in
myogenic cells of rat (L8E63 and RMo) and mouse (C2,
23A2, MRF4) origin including the BC3HI line that does not
fuse (Fig . 10) . H36-a7 mRNA is detected at reduced levels
in human PCl myotube RNA . No H36-a7 mRNA was evi-
dent in poly(A)+ RNA from myotubes that developed from
primary cultures of chick embryo hindlimbs or from the
quail QM7 myogenic line indicating that transcripts with
high homology are absent in avian skeletal muscle . H36-a7
mRNA was not detected in either mouse 1OTI/2 cells or BHK
cells (Fig . 10) .
Discussion
Molecular cloning and sequencing identify H36 as a new
integrin alpha chain, 67. H36-a7 shares extensive features
and homologies common to all known alpha chains, espe-
cially the members of the non-I region subgroup that also
Figure 7 . Immunofluorescence localization of H36-a7 and01 integrin subunits . Double label immunofluorescence staining of primary cul-
tures of newborn rat thigh muscle (A-E) and L8E63 cells (F-I) . (A and D) alpha integrin detected with biotinylated anti-H36 antibody
andrhodamine-avidin . (B andE) 01 integrin detected with 014-1 mAband fluorescein anti-mouse IgG. (FandH) H36-a7 integrin detected
with anti-H36 antibody and rhodamine-antimouse IgG. (G and I) 01 integrin detected with rabbit antiserum against the ßl cytoplasmic
domain and fluorescein-antirabbit IgG. (C) Phase contrast ofA andB . H36-a7 chain staining is restricted to myoblasts and myotubes [A
and D] while 01 integrin is evident on both fibroblasts and myogenic cells (B and E) . Increased H36-a7 chain immunofluorescence and
decreased 01 immunofluorescence are seen on myotubes (mt) (D andE) . Coincidence of alpha and beta chain localization is most evident
on the attached surface of fusing myoblasts (F and G) and on newly formed myotubes (H and I) . Bar, 16 pm .have a characteristic protease cleavage site . Amongst these,
1136-«7 most closely resembles cx6 integrin .
Like all the integrin alpha chains, H36-a7 has a unique cy-
toplasmic domain . This portion of the molecule contains the
sequence GFFKR that is characteristic of all known alpha
chains. The remainder of the cytoplasmic domain (with ex-
ception of residues 1081-1083, SDA) is distinct . The inter-
actions of integrinaß heterodimers with extracellular matrix
proteins, with other cell surface ligands, with complement,
and perhaps with additional molecules may transmit or initi-
ate signals between and within cells, promote cell move-
ment, or in other cases, cell localization . It is generally
believed that the transduction of such signals is mediated
Figure 11. Expression of H36-a7 mRNA in passaged embryonic
day 12 limb bud cells. Cells from day 12 embryo hindlimb buds
were grown and passaged in vitro every 3-4 d as indicated (Kauf-
man et al ., 1991) . PI-P4 represent sequential passages . Poly(A)+
RNAs (5 Wg) from each passage were analyzed by northern blots for
expression ofH36-a7 mRNA . Detection of H36-a7 mRNA in pas-
sage 3 and 4 cells coincides with results obtained by immunofluo-
rescence .
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Figure 10 . Expression of H36-
a7 mRNA in myogenic cells .
Poly(A)+ RNAs were purified
from baby hamster kidney
(BHK), chick embryo myo-
tubes, C2 mouse myotubes,
RMo rat myotubes, L8E63
myotubes, fu-1 cells (a devel-
opmentally defective clone of
L8), BC3H1 mouse myogenic
cells, quail QM7 myotubes,
human PO myotubes, IOTI/2
cells, and myotubes of the
23A2 andMRF4lines (derived
from IOTI/2 cells by treatment
with 5-azacytidine and trans-
fection withMRF4cDNA, re-
spectively) . A, 500 ng ; B, 1 ILg ;
and C, 100ng ofeachpoly(A)
RNA, were electrophoresed in
1% agarosegels, transferred to
GeneScreen Plus, and probed
withlabeled H36-a7 and myo-
genincDNAs . Exposure times
were 12 h (A and B) ; and
72 h (C) .
through interactions of the integrins with the cell cytoskele-
ton and perhaps with other cytoplasmic components as well .
Some molecules involved in these interactions, for example
talin and vinculin, have been identified (Horwitz et al .,
1986 ; Singer and Paradiso, 1981) . The role of beta chains
in the interactions of the integrins with the cytoskeleton
seems preeminent (Hibbs et al ., 1991) and phosphorylation
of specific residues appears to have a regulatory role (Hirst
et al ., 1986 ; Dahl and Grabel, 1989 ; Hillery et al ., 1991 ;
Horvath et al ., 1990) . The functions of the cytoplasmic do-
mains of the integrin alpha chains have not yet been estab-
lished . Since the association ofthe H36-a7 complex with the
cell cytoskeleton can be promoted by cross-linking its ex-
tracellular domains with antibodies (Lowrey and Kaufman,
1989), it is reasonable to predict that ligands in vivomay also
have this effect . Laminin may be one such ligand . The unique
size and sequence of the H36-a7 cytoplasmic domain sug-
gests that it may participate in novel molecular interactions .
Unlike most of the other integrin alpha and beta cytoplasmic
domains, there are no potential sites for phosphorylation in
the H36-a7 cytoplasmic domain . In contrast, numerous sites
ofpotential phosphorylation and four potential glycosylation
sites exist in the extracellular domain (Fig . 4) .
The regulation of expression of the H36-«7 integrin chain
during the development of skeletal muscle appears to be
complex . During development of the myogenic lineage the
expression of H36-«7 is regulated at least twice, by appar-
ently distinct mechanisms (Kaufman and Foster, 1988, 1989 ;
Kaufman et al ., 1991) . During early limb bud formation
654Figure 12 . Immunofluorescence detection of H36-a7 integrin in adult thigh muscle . Cryosections prepared from adult rat thigh muscle
stained with anti-H36 antibody and fluorescein anti-mouse IgG (A and C) . (A and B) cross sections ; (C and D) longitudinal sections .
Bar, 26 gm .
(days 12-15 of embryonic development in the rat) primary
fibers form from precursor cells . The myoblasts which give
rise to these fibers do not express H36-a7 until after terminal
differentiation is well underway . Secondary fibers that com-
prise the bulk of muscle mass, subsequently develop . In con-
trast with those cells which develop into primary fibers,
myoblasts, and their immediate precursors that will form
secondary fibers do express H36-a7. Upon terminal differen-
tiation of these secondary myoblasts there is increased ex-
pression of H36-a7 (George-Weinstein, M ., manuscript
submitted for publication) . Immunofluorescence analyses
(Kaufman et al., 1985, 1991), immunoblots (Fig . 8) and
Northern blots (Figs . 9 and 11) indicate that the regulation
of expression 1136-a7, both early and late in myogenic devel-
opment, is primarily at the level of transcription . Anti-
MyoDl and anti-myogenin antibodies do not detect either
of these myogenic regulatory proteins upon conversion of
H36- precursor cells to H36' cells (Kaufman et al., 1991) .
In contrast, the increased expression of H36-a7 that takes
place during terminal differentiation of secondary myoblasts
(Fig . 9) is accompanied by expression of myogenin . Inhibi-
tion of terminal myogenesis by a variety of means including
incorporation of BrdUrd, growth in low concentrations of
calcium, by an a-amanitin sensitive mutation in RNA poly-
merase II, or by expression of the ras, src, or SV40 large
T antigen oncogenes, all inhibit the increased expression of
H36-a7 without altering its basal level of expression (Kauf-
man et al ., 1985, 1990 ; Haider and Kaufman, manuscript in
preparation) . These results further indicate that expression
of H36-a7 at different stages of myogenesis is regulated by
distinct mechanisms .
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Expression of 1136-a7 is highly select . Immunofluores-
cence analysis of a variety of cells grown in vitro (including
primary cultures of skeletal muscle fibroblasts, cardiac en-
dothelial cells, liver and kidney cells, brain glial cells and
neurites, and stomach and aorta smooth muscle) detected
H36 only on skeletal and cardiac muscle (Kaufman et al .,
1985) . This has since been confirmed using immunoblots
(unpublished data) . H36-a7 expression in the developing rat
embryo likewise appears highly select and developmentally
regulated as shown by immunofluorescence staining of
cryosections prepared from day 12 to 18 rat embryos (Kauf-
man et al ., 1991 ; GeorgeWeinstein, M ., manuscript sub-
mitted for publication) . In addition to localization of H36-a7
in the developing musculature ofthe limb it was also detected
on cells of the dorsal root ganglion (DRG) in the embryo
(George-Weinstein, M ., manuscript submitted for publica-
tion) . Although the molecular identity of 1136-a7 on DRG
cells has not been confirmed by direct biochemical analysis,
two additional mAbs reactive withH36 produce the identical
staining on DRG and skeletal muscle in cryosections . Fi-
nally, conversion of IOTl/2 cells to myogenic cells upon
treatment with azacytidine, or by transfection with myogenic
regulatory genes, results in expression of the H36-cal gene
in the myotubes which subsequently develop.
The expression and association of H36-a7 integrin and
the integrin ßl chain appear to be distinctly regulated dur-
ing myogenesis in vitro . The lack of full coincidence in co-
localization of these two molecules on replicating myoblasts
seen by double label immunofluorescence, and the loss of ßl
and increased expression of H36-a7 integrin on myotubes
supports this . These results also indicate that H36-a7 may
655associate with more than one isoform of beta chain. The
decreased immunofluorescence staining of ßl integrin on
myotubes corresponds with the loss of membrane-associated
fibronectin (Hynes et al ., 1976; Chen, 1977) and with the
increased synthesis (Olwin and Hall, 1985) and assembly of
laminin on the myotube surface (Kuhl et al., 1982 ; Sanes and
Lawrence, 1983). A complete analysis of integrin alpha and
beta chain expression and their association with specific ex-
tracellular matrix proteins is needed to give a full account
of what appears to be complex developmental regulation of
alpha and beta chains during myogenesis.
The role of integrins during myogenesis may be diverse as
they can mediate the interactions of cells with extracellular
matrix proteins, with other cells and with additional mole-
cules, such as complement (for reviews see Akiyama et al.,
1990; Albelda and Buck, 1990; Hemler, 1990; Humphries,
1990). Cell surface attachment (CSAT) antibody (i.e., anti-
01) and other anti-integrin antibodies can detach chick myo-
blasts from the in vitro culture substratum (Neffet al., 1982;
Greve and Gottlieb, 1982; Horwitz et al., 1985). Growth of
myoblasts in vitro on laminin, in contrast to growth on colla-
gen or fibronectin, will selectively maintain myoblast pro-
liferation in vitro, and thereby influence in a quantitative
way the extent of myogenesis (Foster et al., 1987; Ocalan et
al., 1988). The appearance of laminin during the develop-
ment of the limb in vivo also corresponds with the appear-
ance of secondary myoblasts that express H36-a7 (Wein-
stein, M ., manuscript submitted for publication) and with
the onset of increased muscle mass. This coincidence in the
expression of H36-a7 on secondary myoblasts, its binding to
laminin and the consequent effect on myoblast proliferation
strongly suggest that H36-a7 modulates this stage of myo-
genesis in vivo through cell-extracellular matrix interac-
tions. Myogenesis may also be inhibited by CSAT antibody
(Menko and Boettiger, 1987), by growth of myogenic lines
on laminin (Foster et al., 1987), and by addition of fibronec-
tin to these cells (Podleski et al., 1976), further indicating
that extracellular matrix receptor occupancy can profoundly
regulate myogenic differentiation . In addition, mutant myo-
blasts (for example, fu-1 cells; Fig. 10) that express reduced
levels of 1136-a7 do not differentiate, have often lost the nor-
mal control of replication that is essential to myogenesis, and
are tumorigenic (Kaufman and Parks, 1977; Kaufman et al .,
1980). Other myoblasts, selected on the basis of low expres-
sion of H36-a7 fail to interact with each other and do not
fuse to form myotubes, but do biochemically differentiate
(unpublished data) . These results further imply a role for
H36-a7 in cell to cell and extracellular interactions during
muscle differentiation. The integrins on skeletal muscle
fibers may also play a pivotal role in assembly of the myo-
fibril. Drosophila embryos with the lethal myospheroid mu-
tation do not express OPs integrin, undergo defective myo-
genesis and form defective Z-bands (Volk et al., 1990). The
localization of CSAT antibody at myotendinous and neu-
romuscularjunctions suggests that integrins also stabilize in-
teractions between the sarcolemma and extracellular matrix
as well as neuromuscular junctions (Bozyczko et al ., 1989) .
Non-integrin extracellular matrix binding proteins may also
mediate interactions with muscle (Clegg et al., 1988). The
expression ofH36-a7 at different times during the formation
of primary and secondary fibers and its persistence on adult
muscle (Fig. 12) suggests that this alpha chain may have
different functions at different stages ofmuscle development.
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Since the submission of this manuscript, Kramer et al .
(1991) reported the sequence of the first 25 residues at the
amino terminal end ofan integrin isolated from mouse mela-
noma cells and von der Mark et al . (1991) reported the se-
quence of 17 amino acids in an integrin expressed by the
Rugli line of rat myoblasts. These sequences are identical to
that in H36-a7 and both these proteins associate with 01
chains and bind laminin . Based on these similarities it is
likely that these proteins are related or identical to the H36-
a7 integrin chain reported here.
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